298 related articles for article (PubMed ID: 34244432)
1. Landscape of innate lymphoid cells in human head and neck cancer reveals divergent NK cell states in the tumor microenvironment.
Moreno-Nieves UY; Tay JK; Saumyaa S; Horowitz NB; Shin JH; Mohammad IA; Luca B; Mundy DC; Gulati GS; Bedi N; Chang S; Chen C; Kaplan MJ; Rosenthal EL; Holsinger FC; Divi V; Baik FM; Sirjani DB; Gentles AJ; Newman AM; Freud AG; Sunwoo JB
Proc Natl Acad Sci U S A; 2021 Jul; 118(28):. PubMed ID: 34244432
[TBL] [Abstract][Full Text] [Related]
2. Landscape of natural killer cell activity in head and neck squamous cell carcinoma.
Charap AJ; Enokida T; Brody R; Sfakianos J; Miles B; Bhardwaj N; Horowitz A
J Immunother Cancer; 2020 Dec; 8(2):. PubMed ID: 33428584
[TBL] [Abstract][Full Text] [Related]
3. Innate lymphoid cells and cancer: Role in tumor progression and inhibition.
Yuan X; Rasul F; Nashan B; Sun C
Eur J Immunol; 2021 Sep; 51(9):2188-2205. PubMed ID: 34189723
[TBL] [Abstract][Full Text] [Related]
4. Endometrial Tumor Microenvironment Alters Human NK Cell Recruitment, and Resident NK Cell Phenotype and Function.
Degos C; Heinemann M; Barrou J; Boucherit N; Lambaudie E; Savina A; Gorvel L; Olive D
Front Immunol; 2019; 10():877. PubMed ID: 31105699
[TBL] [Abstract][Full Text] [Related]
5. CDX2 enhances natural killer cell-mediated immunotherapy against head and neck squamous cell carcinoma through up-regulating CXCL14.
Wang H; Nan S; Wang Y; Xu C
J Cell Mol Med; 2021 May; 25(10):4596-4607. PubMed ID: 33733587
[TBL] [Abstract][Full Text] [Related]
6. Multi-tissue single-cell analysis deconstructs the complex programs of mouse natural killer and type 1 innate lymphoid cells in tissues and circulation.
McFarland AP; Yalin A; Wang SY; Cortez VS; Landsberger T; Sudan R; Peng V; Miller HL; Ricci B; David E; Faccio R; Amit I; Colonna M
Immunity; 2021 Jun; 54(6):1320-1337.e4. PubMed ID: 33945787
[TBL] [Abstract][Full Text] [Related]
7. Head and neck cancer triggers the internalization of TLR3 in natural killer cells.
Xie L; Pries R; Kesselring R; Wulff S; Wollenberg B
Int J Mol Med; 2007 Oct; 20(4):493-9. PubMed ID: 17786279
[TBL] [Abstract][Full Text] [Related]
8. The breast tumor microenvironment alters the phenotype and function of natural killer cells.
Krneta T; Gillgrass A; Chew M; Ashkar AA
Cell Mol Immunol; 2016 Sep; 13(5):628-39. PubMed ID: 26277898
[TBL] [Abstract][Full Text] [Related]
9. Assessment of Immune Cell Populations in Tumor Tissue and Peripheral Blood Samples from Head and Neck Squamous Cell Carcinoma Patients.
Caruntu A; Moraru L; Surcel M; Munteanu A; Tanase C; Constantin C; Zurac S; Caruntu C; Neagu M
Anal Cell Pathol (Amst); 2021; 2021():2328218. PubMed ID: 34692375
[TBL] [Abstract][Full Text] [Related]
10. Production by human squamous cell carcinoma of a factor inducing activation and proliferation of immune cells.
Hirabayashi H; Yasumura S; Lin WC; Amoscato A; Johnson JT; Herberman RB; Whiteside TL
Arch Otolaryngol Head Neck Surg; 1995 Mar; 121(3):285-92. PubMed ID: 7873144
[TBL] [Abstract][Full Text] [Related]
11. Orchestration of immune response by innate lymphoid cell subtype 2 at various tumor microenvironment, a suitable target for cancer immunotherapy.
Roy R; Das T; Biswas N
Int Rev Immunol; 2024; 43(2):74-82. PubMed ID: 37599626
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive analysis of immune cell enrichment in the tumor microenvironment of head and neck squamous cell carcinoma.
Mito I; Takahashi H; Kawabata-Iwakawa R; Ida S; Tada H; Chikamatsu K
Sci Rep; 2021 Aug; 11(1):16134. PubMed ID: 34373557
[TBL] [Abstract][Full Text] [Related]
13. CHMP2A regulates broad immune cell-mediated antitumor activity in an immunocompetent in vivo head and neck squamous cell carcinoma model.
Yun J; Saddawi-Konefka R; Goldenson B; Al-Msari R; Bernareggi D; Thangaraj JL; Tang S; Patel SH; Luna SM; Gutkind JS; Kaufman D
J Immunother Cancer; 2024 May; 12(5):. PubMed ID: 38702144
[TBL] [Abstract][Full Text] [Related]
14. Conventional NK cells and tissue-resident ILC1s join forces to control liver metastasis.
Ducimetière L; Lucchiari G; Litscher G; Nater M; Heeb L; Nuñez NG; Wyss L; Burri D; Vermeer M; Gschwend J; Moor AE; Becher B; van den Broek M; Tugues S
Proc Natl Acad Sci U S A; 2021 Jul; 118(27):. PubMed ID: 34183415
[TBL] [Abstract][Full Text] [Related]
15. Assessment of the change in cetuximab-induced antibody-dependent cellular cytotoxicity activity of natural killer cells by steroid.
Kumai T; Oikawa K; Aoki N; Kimura S; Harabuchi Y; Kobayashi H
Head Neck; 2016 Mar; 38(3):410-6. PubMed ID: 25352398
[TBL] [Abstract][Full Text] [Related]
16. NK Cell Development in Times of Innate Lymphoid Cell Diversity.
Stokic-Trtica V; Diefenbach A; Klose CSN
Front Immunol; 2020; 11():813. PubMed ID: 32733432
[TBL] [Abstract][Full Text] [Related]
17. Human natural killer cells and other innate lymphoid cells in cancer: Friends or foes?
Vacca P; Munari E; Tumino N; Moretta F; Pietra G; Vitale M; Del Zotto G; Mariotti FR; Mingari MC; Moretta L
Immunol Lett; 2018 Sep; 201():14-19. PubMed ID: 30439479
[TBL] [Abstract][Full Text] [Related]
18. Cetuximab-activated natural killer and dendritic cells collaborate to trigger tumor antigen-specific T-cell immunity in head and neck cancer patients.
Srivastava RM; Lee SC; Andrade Filho PA; Lord CA; Jie HB; Davidson HC; López-Albaitero A; Gibson SP; Gooding WE; Ferrone S; Ferris RL
Clin Cancer Res; 2013 Apr; 19(7):1858-72. PubMed ID: 23444227
[TBL] [Abstract][Full Text] [Related]
19. Presence of innate lymphoid cells in pleural effusions of primary and metastatic tumors: Functional analysis and expression of PD-1 receptor.
Tumino N; Martini S; Munari E; Scordamaglia F; Besi F; Mariotti FR; Bogina G; Mingari MC; Vacca P; Moretta L
Int J Cancer; 2019 Sep; 145(6):1660-1668. PubMed ID: 30856277
[TBL] [Abstract][Full Text] [Related]
20. PD-L1 Mediates Dysfunction in Activated PD-1
Concha-Benavente F; Kansy B; Moskovitz J; Moy J; Chandran U; Ferris RL
Cancer Immunol Res; 2018 Dec; 6(12):1548-1560. PubMed ID: 30282672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
